Countries must move beyond seeing AI as a race, where one side must beat the other

The international order is becoming more multi-polar, and the AI world is no exception. Instead of trying to “win the AI race ...
Le Lézard

Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently received the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for the Phase II ...